DrugPatentWatch Database Preview
Details for Patent: RE38551
Email this page to a colleague
» See Plans and PricingWhich drugs does patent RE38551 protect, and when does it expire?
Patent RE38551 protects VIMPAT and is included in three NDAs.
This patent has twenty-two patent family members in eleven countries.
Summary for Patent: RE38551
| Title: | Anticonvulsant enantiomeric amino acid derivatives |
| Abstract: | The present invention is directed to a compound in the R configuration about the asymmetric carbon in the following formula: ##STR1## pharmaceutical compositions containing same and the use thereof in treating CNS disorders in animals. |
| Inventor(s): | Kohn; Harold (Chapel Hill, NC) |
| Assignee: | Research Corporation Technologies, Inc. (Tucson, AZ) |
| Application Number: | 10/058,634 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent RE38551 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent RE38551
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | VIMPAT | lacosamide | SOLUTION;INTRAVENOUS | 022254-001 | Oct 28, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | METHOD OF TREATING, AS MONOTHERAPY OR ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER WHEN ORAL ADMINISTRATION IS TEMPORARILY NOT FEASIBLE | Start Trial | ||
| Ucb Inc | VIMPAT | lacosamide | SOLUTION;INTRAVENOUS | 022254-001 | Oct 28, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | METHOD OF TREATING, AS INITIAL LOADING DOSE FOR MONOTHERAPY OR ADJUNCTIVE THERAPY, PARTIAL ONSET-SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS OR OLDER WHEN ORAL ADMINISTRATION IS TEMPORARILY NOT FEASIBLE | Start Trial | ||
| Ucb Inc | VIMPAT | lacosamide | SOLUTION;ORAL | 022255-001 | Apr 20, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | METHOD OF TREATING PARTIAL ONSET SEIZURES IN PATIENTS 4 YEARS OF AGE AND OLDER | Start Trial | ||
| Ucb Inc | VIMPAT | lacosamide | SOLUTION;ORAL | 022255-001 | Apr 20, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | METHOD OF TREATING, AS INITIAL LOADING DOSE FOR MONOTHERAPY OR ADJUNCTIVE THERAPY, PARTIAL ONSET-SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS OR OLDER | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE38551
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 202079 | Start Trial | |||
| Austria | 268169 | Start Trial | |||
| Australia | 2539497 | Start Trial | |||
| Australia | 4846499 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
